Research & Development (Pharma & Healthcare)

Pharma & Healthcare R&D Reports

Research & Development (Pharma & Healthcare) Market Research Reports, Industry Analysis and Trends

 

Publication Single User License (PDF) Price
R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

Date Published: Sep 15 2013
$7,941.00
Antibody Report Bundle

Antibody Report Bundle

Date Published: Mar 18 2014

Market Reserach Reports, Inc is running a promotion until the end of April for a bundle of four antibody-related reports with a 50% discount on the list price (or four reports for the price of two).

To see each report's table of contents and details please visit following links:

$4,766.00
R&D Productivity - The State of Research and Development in the BioPharmaceutical Industry

R&D Productivity - The State of Research and Development in the BioPharmaceutical Industry

Date Published: Apr 15 2013

R&D Productivity - The State of Research and Development in the BioPharmaceutical Industry

Summary

$3,900.00
Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

Date Published: Jul 15 2013

Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

Summary

Although immunotherapy was first recognized over 100 years ago, it has only become an important therapeutic tool in recent decades. The immune system can be harnessed in one of several ways to tackle various diseases such as cancer, infection, auto-immune disease and inflammatory diseases.

$3,900.00
Stem Cell Research Market to 2017

Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D

Date Published: Nov 22 2011

Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D

 

Summary

 
$3,500.00
Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure

Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure

Date Published: Jul 6 2011

Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure

 

Summary

 
$2,975.00
Antibody Technologies and Attrition Rates – an industry analysis 2013

Antibody Technologies and Attrition Rates – an industry analysis 2013

Date Published: Mar 18 2013
$2,960.00
Global Pharmaceutical and Biotechnology Outlook 2014 :Rising Stars

Global Pharmaceutical and Biotechnology Outlook 2014 :Rising Stars

Date Published: Jan 14 2014
$2,500.00
Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech

Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech

Date Published: Jan 14 2014
$2,500.00
Innovative Drug Delivery Systems Opportunities for Generic & Specialty Pharmaceutical companies

Innovative Drug Delivery Systems Opportunities for Generic & Specialty Pharmaceutical companies

Date Published: Feb 24 2014
There are more than 1400 sustained or controlled release drugs have been approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of overall international pharmaceutical market. The utilization of generic in terms of volume is higher in the US and lower in Japan, 89% and 24% respectively.
 
$2,500.00
Therapeutic Class Overview: Newer Oral Anti Androgens – Expanding Role in the treatment Paradigm of Prostate Cancer

Therapeutic Class Overview: Newer Oral Anti Androgens – Expanding Role in the treatment Paradigm of Prostate Cancer

Date Published: Feb 24 2014
XTANDI (Enzalutamide) – Does it have potential to compete against ARN-509 in earlier setting?
Zytiga (Abiraterone Acetate) – Ongoing Combination trials creates potential beyond Patent Expiry
 
$2,500.00
Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

Date Published: Mar 9 2012

Synopsis

  • This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey.
  • The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior marketing decision makers and leading supplier organizations.
$2,000.00
Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

Date Published: Mar 9 2012

Synopsis

  • This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey.
  • The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa and Middle East.
$2,000.00
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014

Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014

Date Published: Mar 11 2014
Biosimilar and Biosuperior Therapeutic Antibodies 2014
 
The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of March 2014.
 
$1,514.00
CHEMISTS & PHARMACIES (Global) - Industry Report

CHEMISTS & PHARMACIES (Global) - Industry Report

Date Published: Feb 1 2014

Plimsoll’s CHEMISTS & PHARMACIES (Global) analysis is the most definitive and accurate study of the CHEMISTS & PHARMACIES (Global) sector in 2014.

The report is split into two sections and uses both a written and graphical analysis – analysing the 500 largest CHEMISTS & PHARMACIES (Global) companies.

The CHEMISTS & PHARMACIES (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis.

$1,500.00
Therapeutic Class Overview : New Avatars Of Microbes Super Bugs A Growing Threat Worldwide

Therapeutic Class Overview : New Avatars Of Microbes Super Bugs A Growing Threat Worldwide

Date Published: Feb 24 2014
$1,500.00
CHEMISTS & PHARMACIES (European) - Industry Report

CHEMISTS & PHARMACIES (European) - Industry Report

Date Published: Feb 1 2014

Plimsoll’s CHEMISTS & PHARMACIES (European) analysis is the most definitive and accurate study of the CHEMISTS & PHARMACIES (European) sector in 2014.

The report is split into two sections and uses both a written and graphical analysis – analysing the 550 largest CHEMISTS & PHARMACIES (European) companies.

The CHEMISTS & PHARMACIES (European) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis.

$1,310.00
Influence of Antibody Attributes on Clinical Success – A Technology and Coporate Benchmark Analysis

Influence of Antibody Attributes on Clinical Success – A Technology and Coporate Benchmark Analysis

Date Published: Mar 24 2013
How do antibody characteristics impact clinical success?
 
$1,203.00
Stem Cell Research in India 2012

Stem Cell Research in India 2012

Date Published: Jul 6 2012
The stem cell research in India is in its nascent stage and is gradually on a growth path of acceptance by people. The market is still in a phase of conducting research to establish itself as one of the best therapies for the widely prevalent incurable lifestyle diseases. Awareness campaigns and doctors are playing a key role educating people and especially would-be parents about the benefits associated with preserving stem cells.
 
$795.00
Competitor Analysis: TNF Antibodies –Biosimilars and Biosuperiors

Competitor Analysis: TNF Antibodies –Biosimilars and Biosuperiors

Date Published: Mar 11 2014
TNF Antibodies –Biosimilars and Biosuperiors
 
$551.00

Pages

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianB. Braun, Cobham, fiserv, Harris, Wipro, AonMunich Re, Lotte Chemical, National Post, First Data